The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Cancer can often be difficult to detect in the early stages, particularly if it is a more 'subtle' form of the disease. So ...

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

A groundbreaking new therapy for ovarian cancer is being trialled on a Brisbane woman, in an Australian-first, which aims to ...

A doctor has shared five symptoms of a type of cancer she says 'everyone' should know, as it can be 'difficult to detect' if ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.